VEGF Antikörper (AA 27-233)
Kurzübersicht für VEGF Antikörper (AA 27-233) (ABIN2735207)
Target
Alle VEGF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 27-233
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Human recombinant protein fragment corresponding to amino acids 27-233 of human VEGFA (NP_003367) produced in E.coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB: 1:200 - 1:1000, IHC 1:50, IF 1:100,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
-
: "A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review." in: Endocrine pathology, Vol. 28, Issue 1, pp. 75-82, (2017) (PubMed).
: "The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis." in: Oncotarget, Vol. 8, Issue 9, pp. 15520-15538, (2017) (PubMed).
-
: "A Somatic HIF2α Mutation-Induced Multiple and Recurrent Pheochromocytoma/Paraganglioma with Polycythemia: Clinical Study with Literature Review." in: Endocrine pathology, Vol. 28, Issue 1, pp. 75-82, (2017) (PubMed).
-
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
Andere Bezeichnung
- VEGF
-
Molekulargewicht
- 23.8 kDa
-
Gen-ID
- 7422
-
NCBI Accession
- NM_001025366
-
HGNC
- 7422
Target
-